The recent announcement of results from the Reduction of Cardiovascular Events with EPA Intervention Trial (REDUCE-IT) study, which found a highly significant reduction in cardiovascular events using Vascepa 4 g per day, suggests how these anti-inflammatory benefits may cause reductions in clinical endpoints.
← all excerpts
Importance of maintaining a low omega-6/omega-3 ratio for reducing inflammation.
1
—
—